Symposium : Ubiquitin family and Cancer 🗓 🗺
Our understanding of the importance of the ubiquitin family of modifiers in physiology and medicine has evolved tremendously during the past decade, thanks to the exponential accumulation of data demonstrating the paramount role of these proteins in the fine regulation of most physiological and pathological processes. In particular, numerous studies have established that protein modification by ubiquitin or ubiquitin-like proteins such as SUMO, NEDD8 or LC3/GABARAP plays critical roles in cancer.
Given these remarkable developments and the practical need for identification of novel targets for anticancer therapy, our symposium will offer a unique possibility for the local scientific community to discuss and get more insight into the new global view that emerges regarding the mechanism regulated by members of the ubiquitin-family and their important roles in human oncological diseases. Our keynote speakers will enrich the discussion by presenting overviews as well as their most recent data concerning the fundamental and clinical roles of the ubiquitin-family in the development of various types of cancer. Our program will be completed with selected oral presentations from the audience attending this symposium.
- Open to oral and poster presentation
- Registration is free but mandatory